Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05075733 · ClinicalTrials.gov registry record
Current Scope of Practice of Today's Hepatopancreatobiliary Surgeons: A Survey of AHPBA Members
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 172
- Enrollment target
NCT05075733: Completed study, sponsored by Henry Ford Health System.
NCT05075733 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 172 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05075733 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
Study Summary
The development of multiple training pathways to foster competent hepatopancreatobiliary (HPB) surgeons has led to a diverse group of surgical subspecialists. The objective of our study was to determine the current scope of practice of today's HPB surgeons. An online survey was sent to all the Americas Hepato-Pancreato-Biliary Association's members to assess the current scope of practice of today's HPB surgeons. We found very few surgeons run a solo HPB practice, so changes may be needed in HPB training to provide uniformity and enhance the scope of practice for future HPB surgeons.
Primary Outcome
Response to survey
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2015-02-01 |
What the finished NCT05075733 record still lists
NCT05075733 is an observational study that tracks outcomes without assigning an intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT05075733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05075733 about?
NCT05075733 is a clinical study titled "Current Scope of Practice of Today's Hepatopancreatobiliary Surgeons: A Survey of AHPBA Members". The development of multiple training pathways to foster competent hepatopancreatobiliary (HPB) surgeons has led to a diverse group of surgical subspecialists. The objective of our study was to determine the current scope of practice of today's HPB surgeons. An online survey was sent to all the Ameri...
What is the current status of trial NCT05075733?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2014-12-01. Estimated completion is 2015-02-01.
What interventions are being tested in trial NCT05075733?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05075733?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI